DE69306513D1 - Neue kardioaktive Zyklopentaperhydrophenanthrene-17-beta-(hydroxy oder alkoxy)-17-alpha-(aryl oder heterozyklyl)-3-beta Derivate, ein Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon - Google Patents

Neue kardioaktive Zyklopentaperhydrophenanthrene-17-beta-(hydroxy oder alkoxy)-17-alpha-(aryl oder heterozyklyl)-3-beta Derivate, ein Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon

Info

Publication number
DE69306513D1
DE69306513D1 DE69306513T DE69306513T DE69306513D1 DE 69306513 D1 DE69306513 D1 DE 69306513D1 DE 69306513 T DE69306513 T DE 69306513T DE 69306513 T DE69306513 T DE 69306513T DE 69306513 D1 DE69306513 D1 DE 69306513D1
Authority
DE
Germany
Prior art keywords
beta
alkoxy
aryl
alpha
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69306513T
Other languages
English (en)
Other versions
DE69306513T2 (de
Inventor
Mauro Gobbini
Mara Ferrandi
Marco Frigerio
Piero Melloni
Marco Torri
Loredana Valentino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority to DE69306513T priority Critical patent/DE69306513T2/de
Publication of DE69306513D1 publication Critical patent/DE69306513D1/de
Application granted granted Critical
Publication of DE69306513T2 publication Critical patent/DE69306513T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69306513T 1992-09-29 1993-09-22 Neue kardioaktive Zyklopentaperhydrophenanthrene-17-beta-(hydroxy oder alkoxy)-17-alpha-(aryl oder heterozyklyl)-3-beta Derivate, ein Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon Expired - Fee Related DE69306513T2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE69306513T DE69306513T2 (de) 1992-09-29 1993-09-22 Neue kardioaktive Zyklopentaperhydrophenanthrene-17-beta-(hydroxy oder alkoxy)-17-alpha-(aryl oder heterozyklyl)-3-beta Derivate, ein Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4232656A DE4232656C2 (de) 1992-09-29 1992-09-29 Cyclopentanperhydrophenanthren-17-furyl-3ß-derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutischen Zusammensetzungen
DE69306513T DE69306513T2 (de) 1992-09-29 1993-09-22 Neue kardioaktive Zyklopentaperhydrophenanthrene-17-beta-(hydroxy oder alkoxy)-17-alpha-(aryl oder heterozyklyl)-3-beta Derivate, ein Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon

Publications (2)

Publication Number Publication Date
DE69306513D1 true DE69306513D1 (de) 1997-01-23
DE69306513T2 DE69306513T2 (de) 1997-05-15

Family

ID=6469153

Family Applications (2)

Application Number Title Priority Date Filing Date
DE4232656A Expired - Fee Related DE4232656C2 (de) 1992-09-29 1992-09-29 Cyclopentanperhydrophenanthren-17-furyl-3ß-derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutischen Zusammensetzungen
DE69306513T Expired - Fee Related DE69306513T2 (de) 1992-09-29 1993-09-22 Neue kardioaktive Zyklopentaperhydrophenanthrene-17-beta-(hydroxy oder alkoxy)-17-alpha-(aryl oder heterozyklyl)-3-beta Derivate, ein Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE4232656A Expired - Fee Related DE4232656C2 (de) 1992-09-29 1992-09-29 Cyclopentanperhydrophenanthren-17-furyl-3ß-derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutischen Zusammensetzungen

Country Status (9)

Country Link
US (1) US5521167A (de)
EP (1) EP0590489B1 (de)
JP (1) JPH06211893A (de)
AT (1) ATE146184T1 (de)
DE (2) DE4232656C2 (de)
DK (1) DK0590489T3 (de)
ES (1) ES2095542T3 (de)
GR (1) GR3021998T3 (de)
HK (1) HK1005879A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19633349A1 (de) * 1996-08-19 1998-02-26 Sigma Tau Ind Farmaceuti Neue 6-Hydroxy- und 6-Oxo-androstan-Derivate, die auf das kardiovaskuläre System wirken und pharmazeutische Zusammensetzungen, die diese enthalten
US6093389A (en) * 1997-12-01 2000-07-25 American Cyanamid Company Methods and compositions for attracting and controlling termites
US8084446B2 (en) 2005-04-26 2011-12-27 Eric Marchewitz Use of DHEA derivatives for enhancing physical performance

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2938030A (en) * 1956-10-03 1960-05-24 Ciba Pharm Prod Inc New steroids substituted by a heterocyclic nitrogen-containing ring in 17-position
DE1227015B (de) * 1963-01-23 1966-10-20 Bayer Ag Verfahren zur Herstellung von 3beta-Hydroxy-(bzw.-Acyloxy)-steroid-20-amidylhydrazonen der Pregnanreihe
US3398138A (en) * 1966-05-24 1968-08-20 American Home Prod Novel cardenolides and derivatives
US3436390A (en) * 1966-05-24 1969-04-01 American Home Prod 4,4-dihydroxy-2-butenoic acid lactones
FR2414514A1 (fr) * 1978-01-11 1979-08-10 Roussel Uclaf Nouveaux derives steroides 17aaryle ou aheteroaryle, leur procede de preparation et leur application comme medicament
IE53463B1 (en) * 1981-06-15 1988-11-23 Akzo Nv Mono-and bisquaternary ammonium derivatives of 2 beta,16 beta-d-amino-5 alpha-androstane derivatives and pharmaceutical preparations containing same
US5380840A (en) * 1985-09-12 1995-01-10 The Upjohn Company Triazinylpiperazinyl steroids
GB8916636D0 (en) * 1989-07-20 1989-09-06 Erba Carlo Spa Steroid ethers
DE4221636C1 (de) * 1992-07-01 1994-03-31 Sigma Tau Ind Farmaceuti Cyclopentanperhydrophenanthren-17beta-(3-furyl)-3-Derivate
DE4227605C2 (de) * 1992-08-20 1995-02-16 Sigma Tau Ind Farmaceuti 17-Hydroxyiminomethyl-14beta-hydroxy-5ß-androstan-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die dieselben enthalten
US5252630A (en) * 1992-10-15 1993-10-12 Duke University Antifouling coating and method for using same

Also Published As

Publication number Publication date
US5521167A (en) 1996-05-28
HK1005879A1 (en) 1999-01-29
DE4232656A1 (de) 1994-03-31
JPH06211893A (ja) 1994-08-02
ATE146184T1 (de) 1996-12-15
EP0590489A2 (de) 1994-04-06
DE69306513T2 (de) 1997-05-15
DK0590489T3 (da) 1996-12-30
DE4232656C2 (de) 1995-01-12
ES2095542T3 (es) 1997-02-16
EP0590489B1 (de) 1996-12-11
EP0590489A3 (en) 1994-06-29
GR3021998T3 (en) 1997-03-31

Similar Documents

Publication Publication Date Title
DE69713526D1 (de) Lösliche prodrugs von paclitaxel
DE69023947D1 (de) Fluorierte Gallensäure-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen daraus.
AP9701041A0 (en) Pyridylpyrrole compounds.
DE69306212D1 (de) Kardioaktive 17-aryl und 17-heterozyklyl-14 beta-5alpha-Androstane, Androstene und Androstadiene, ein Verfahren zu ihrer Herstellung und pharmazeutische Präperate davon
ATE196768T1 (de) Neue 6-hydroxy und 6-oxo-androstan verbindungen mit kardioaktivität und pharmazeutische präparate davon
DE69020781D1 (de) Gallensäure-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen daraus.
ATE152118T1 (de) Kardioaktive 17b-(3-furyl) und 17b-(4- pyridazinyl)-5beta, 14beta-androstan derivate, verfahren zu ihrer herstellung und pharmazeutische präparate davon
DE69306513D1 (de) Neue kardioaktive Zyklopentaperhydrophenanthrene-17-beta-(hydroxy oder alkoxy)-17-alpha-(aryl oder heterozyklyl)-3-beta Derivate, ein Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon
DE69315501D1 (de) Neue 17-Hydroxyiminomethyl-5beta, 14beta-Androstan-Derivate, kardioaktives Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon
DE69307071T2 (de) Kardioaktive 17B-aryl und 17B-heterozyklyl-5-beta,14-beta-Androstan-Derivate,ein Verfahren zu ihrer Herstellung und pharmazeutische Phäparate davon
DE69500517D1 (de) Neue Hydrazino und Hydroxyamino-14-beta-Hydroxyandrostan-Derivate mit kardiotonischer Aktivität, ein Verfahren zu ihrer Herstellung und pharmaceutische Präparate davon
ATE191462T1 (de) Im kardiovaskulären system aktive seco-d- steroide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zubereitungen
DE69506671D1 (de) Auf das cardiovaskuläre System wirksame 1,5-disubstituierte 7a-methylperhydroinden-3a-ol-Derivate, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
DE69603793D1 (de) Kardioaktive 17-Hydroxyiminoalkyl- und 17-Hydroxyiminomethylalkenyl-Steroid-Derivate, ein Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon
ATE163424T1 (de) Neue 17-(3-imino-2-alkyl-propenyl)-5beta-14beta- androstanderivate, zur behandlung von kardiovaskulären erkrankungen, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee